» Articles » PMID: 23476767

High Frequency of Fibromyalgia in Patients with Psoriatic Arthritis: a Pilot Study

Overview
Journal Arthritis
Specialty Rheumatology
Date 2013 Mar 12
PMID 23476767
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background. Widespread pain from fibromyalgia syndrome (FMS) is observed in patients with psoriatic arthritis (PsA). We hypothesized that there is increased frequency of FMS in patients with PsA that contributes to fatigue and pain. Method. We prospectively enrolled patients with PsA based on the Classification criteria for Psoriatic Arthritis and healthy subjects were used as controls. The frequency of FMS was determined using London Fibromyalgia Epidemiologic Study Screening Questionnaire (LFESSQ) and Symptoms Intensity scale (SIs). Results. 34 PsA patients and 44 controls fulfilled the inclusion criteria. Median age of PsA patients was 52 years with 53.33% females. Median age of controls was 50.5 years with 59% females. FMS was present in 53.33% of PsA patients compared to 4.54% of the controls (P < 0.001), based on LFESSQ. 37.50% of PsA had FMS compared to 6.66% of controls (P < 0.001) based on SIs. There was a significant correlation between LFESSQ and SIs in the psoriatic group (P = 0.00243). 76.66% of PsA patients complained of fatigue compared to 40.90% of controls, but the mean fatigue score between the two groups was comparable (5.03 versus 5.18). Conclusion. FMS-associated pain and fatigue are significantly more frequent in patients with PsA compared to controls.

Citing Articles

Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals.

Ribeiro A, Singla S, Chandran V, Chronis N, Liao W, Lindsay C Rheumatol Adv Pract. 2024; 8(3):rkae074.

PMID: 38912423 PMC: 11193309. DOI: 10.1093/rap/rkae074.


Relationship of pain and fatigue with health-related quality of life and work in patients with psoriatic arthritis on TNFi: results of a multi-national real-world study.

Conaghan P, Alten R, Deodhar A, Sullivan E, Blackburn S, Tian H RMD Open. 2020; 6(2).

PMID: 32611650 PMC: 7425192. DOI: 10.1136/rmdopen-2020-001240.


Fibromyalgia Syndrome and Vitiligo: A Novel Association.

Khudhair O, Gorial F, Hameed A Arch Rheumatol. 2018; 33(2):174-180.

PMID: 30207563 PMC: 6117140. DOI: 10.5606/ArchRheumatol.2018.6524.


Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.

Rifbjerg-Madsen S, Christensen A, Christensen R, Hetland M, Bliddal H, Kristensen L PLoS One. 2017; 12(7):e0180014.

PMID: 28686639 PMC: 5501437. DOI: 10.1371/journal.pone.0180014.


Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.

Torre-Alonso J, Carmona L, Moreno M, Galindez E, Babio J, Zarco P Rheumatol Int. 2017; 37(8):1239-1248.

PMID: 28389856 DOI: 10.1007/s00296-017-3702-9.


References
1.
Wolfe F, Rasker J . The Symptom Intensity Scale, fibromyalgia, and the meaning of fibromyalgia-like symptoms. J Rheumatol. 2006; 33(11):2291-9. View

2.
White K, Speechley M, Harth M, Ostbye T . The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol. 1999; 26(7):1570-6. View

3.
Wolfe F, Hawley D, Wilson K . The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996; 23(8):1407-17. View

4.
Inglis J, Notley C, Essex D, Wilson A, Feldmann M, Anand P . Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. 2007; 56(12):4015-23. DOI: 10.1002/art.23063. View

5.
MIDDLETON G, McFarlin J, Lipsky P . The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum. 1994; 37(8):1181-8. DOI: 10.1002/art.1780370812. View